Welcome Guest | Register / Login

Europe Opioids Drug Market Forecast 2019-2027

Table of Contents

1.RESEARCHSCOPE
1.1.STUDYGOALS
1.2.SCOPEOFTHEMARKETSTUDY
1.3.WHOWILLFINDTHISREPORTUSEFUL?
1.4.STUDYANDFORECASTINGYEARS
2.RESEARCHMETHODOLOGY
2.1.SOURCESOFDATA
2.1.1.SECONDARYDATA
2.1.2.PRIMARYDATA
2.2.TOPDOWNAPPROACH
2.3.BOTTOM-UPAPPROACH
2.4.DATATRIANGULATION
3.EXECUTIVESUMMARY
3.1.MARKETSUMMARY
3.2.KEYFINDINGS
3.2.1.OXYCODONEHOLDSTHELARGESTMARKETSHAREINTERMSOFPRODUCT
3.2.2.ANESTHESIAISTHEMAJORLYUSEDAPPLICATION
4.MARKETDYNAMICS
4.1.MARKETSCOPE&DEFINITION
4.2.MARKETDRIVERS
4.2.1.INCREASINGROADACCIDENTSANDSURGICALPROCEDURES
4.2.2.ESCALATINGPALLIATIVECAREFORPATIENTSSUFFERINGINTENSELY
4.2.3.USAGEOFABUSEDETERRENTFORMULATIONSTORESTRICTTHEOPIOIDABUSE
4.2.4.GROWINGOCCURRENCEOFCHRONICPAIN
4.3.MARKETRESTRAINTS
4.3.1.MISUSEOFOPIOIDS
4.3.2.STRINGENTREGULATORYFRAMEWORK
4.4.MARKETOPPORTUNITIES
4.4.1.INCREASINGUSEOFEXTENDED-RELEASEOPIOIDFORMULATIONS
4.4.2.WIDERANGEOFAPPLICATIONSOFOPIOIDSINTHETHERAPEUTICMANAGEMENT
4.5.MARKETCHALLENGES
4.5.1.INCREASINGNUMBEROFLAWSUITSCASESAGAINSTOPIOIDSMANUFACTURERS
4.5.2.RISINGOCCURRENCEOFDEATHSRELATEDTOOPIOIDOVERDOSE
5.MARKETBYPRODUCTS
5.1.BUPRENORPHINE
5.2.FENTANYL
5.3.HYDROCODONE
5.4.MORPHINE
5.5.OXYCODONE
5.6.TRAMADOL
5.7.OTHERPRODUCTS
6.MARKETBYAPPLICATION
6.1.PAINRELIEF
6.1.1.CANCERPAIN
6.1.2.POSTOPERATIVEPAINMANAGEMENT
6.1.3.LOWBACKPAIN
6.1.4.ORTHOPEDIC
6.1.5.NEUROPATHIC
6.1.6.FIBROMYALGIA
6.2.ANESTHESIA
6.3.COUGHSUPPRESSION
6.4.DIARRHEASUPPRESSION
6.5.DEADDICTION
7.KEYANALYTICS
7.1.PORTER'SFIVEFORCEMODEL
7.1.1.THREATOFNEWENTRANTS
7.1.2.THREATOFSUBSTITUTE
7.1.3.BARGAININGPOWEROFSUPPLIERS
7.1.4.BARGAININGPOWEROFBUYERS
7.1.5.THREATOFCOMPETITIVERIVALRY
7.2.PIPELINEANALYSIS
7.3.INDUSTRYEVENTSINOPIOIDDRUGSMARKET
7.4.TECHNOLOGIESADVANCEMENT
7.5.OPPORTUNITYMATRIX
8.GEOGRAPHICALANALYSIS
8.1.EUROPE
8.1.1.GERMANY
8.1.2.FRANCE
8.1.3.THEUNITEDKINGDOM
8.1.4.SPAIN
8.1.5.ITALY
8.1.6.RESTOFEUROPE
9.COMPETITIVELANDSCAPE
9.1.MARKETPOSITIONANALYSIS
9.2.COMPANYPROFILES
9.2.1.ACURAPHARMACEUTICALS,INC.
9.2.2.ALLERGANPLC
9.2.3.BIODELIVERYSCIENCESINTERNATIONAL,INC.
9.2.4.CIPHERPHARMACEUTICALSINC.
9.2.5.COLLEGIUMPHARMACEUTICAL,INC.
9.2.6.DAIICHISANKYO,INC.
9.2.7.EGALETCORP.
9.2.8.HIKMAPHARMACEUTICALSPLC
9.2.9.INDIVIORINC.
9.2.10.INSYSTHERAPEUTICS,INC.
9.2.11.JANSSENPHARMACEUTICALS,INC.
9.2.12.JOHNSON&JOHNSON
9.2.13.LANNETTCO.INC.
9.2.14.LUPINLTD.
9.2.15.MYLANNV
9.2.16.PFIZERINC.
9.2.17.PURDUEPHARMALP
9.2.18.SANOFI-AVENTISS.A.
9.2.19.SUNPHARMACEUTICALINDUSTRIESLIMITED(SUNPHARMA)
9.2.20.TEVAPHARMACEUTICALINDUSTRIESLTD.


List Of Tables

TABLE1EUROPEOPIOIDSDRUGMARKET2019-2027($MILLION)
TABLE2ANESTHETICEFFECTSOFDRUGSATDIFFERENTOPIOIDRECEPTORS
TABLE3FDAAPPROVEDOPIOIDSWITHADFLABELLING
TABLE4NUMBEROFLAWSUITSCASESSETTLEDBYOPIOIDSMANUFACTURINGCOMPANIESANDPHARMACIES2015-2027
TABLE5EUROPEOPIOIDSDRUGSMARKETBYPRODUCTS2019-2027($MILLION)
TABLE6EUROPEBUPRENORPHINEMARKET2019-2027($MILLION)
TABLE7EUROPEFENTANYLMARKET2019-2027($MILLION)
TABLE8EUROPEHYDROCODONEMARKET2019-2027($MILLION)
TABLE9EUROPEMORPHINEMARKET2019-2027($MILLION)
TABLE10EUROPEOXYCODONEMARKET2019-2027($MILLION)
TABLE11EUROPETRAMADOLMARKET2019-2027($MILLION)
TABLE12EUROPEOTHERPRODUCTSMARKET2019-2027($MILLION)
TABLE13EUROPEOPIOIDSDRUGSMARKETBYAPPLICATION2019-2027($MILLION)
TABLE14EUROPEOPIOIDSDRUGSMARKETBYAPPLICATION2019-2027($MILLION)
TABLE15EUROPEPAINRELIEFMARKET2019-2027($MILLION)
TABLE16EUROPEPAINRELIEFMARKETBYTYPES2019-2027($MILLION)
TABLE17EUROPECANCERPAINMARKET2019-2027($MILLION)
TABLE18EUROPEPOSTOPERATIVEPAINMANAGEMENTMARKET2019-2027($MILLION)
TABLE19EUROPELOWBACKPAINMARKET2019-2027($MILLION)
TABLE20EUROPEORTHOPEDICMARKET2019-2027($MILLION)
TABLE21EUROPENEUROPATHICMARKET2019-2027($MILLION)
TABLE22EUROPEFIBROMYALGIAMARKET2019-2027($MILLION)
TABLE23EUROPEANESTHESIAMARKET2019-2027($MILLION)
TABLE24EUROPECOUGHSUPPRESSIONMARKET2019-2027($MILLION)
TABLE25EUROPEDIARRHEASUPPRESSIONMARKET2019-2027($MILLION)
TABLE26EUROPEDEADDICTIONMARKET2019-2027($MILLION)
TABLE27PIPELINEANALYSESOFOPIOIDDRUGS
TABLE28EUROPEOPIOIDSDRUGSMARKETBYCOUNTRY2019-2027($MILLION)


List Of Figures

FIGURE1EUROPEOPIOIDSDRUGMARKET2019-2027($MILLION)
FIGURE2EUROPEOPIOIDSDRUGSMARKETSHAREBYPRODUCTS2018&2027(%)
FIGURE3EUROPEOPIOIDSDRUGSMARKETSHAREBYAPPLICATION2018&2027(%)
FIGURE4PORTER'SFIVEFORCEMODEL
FIGURE5EUROPEOPIOIDSDRUGSMARKETREGIONALOUTLOOK2018&2027(%)
FIGURE6GERMANYOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE7FRANCEOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE8THEUNITEDKINGDOMOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE9SPAINOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE10ITALYOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE11RESTOFEUROPEOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE12OPIOIDSMARKETPOSITIONANALYSIS2017

Single User License: This License type does not allow the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Inkwood Research
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy